1.Development of a pretreatment workstation for detecting free silica levels in dust
Jian WU ; Yuqiao ZHENG ; Meng LUO ; Mengping ZHANG ; Junyi HUANG ; Fei SHEN ; Feng ZHANG ; Sheng FU ; Xuelei CHEN ; Zongli HUO ; Banghua WU
China Occupational Medicine 2025;52(4):455-459
Objective To investigate an automated pretreatment technology for detecting levels of free silica in workplace dust. Methods An fully automated pretreatment workstation for detecting free silica levels in workplace dust was developed by integrating graphite-controlled digestion temperature, online-controlled dilution of digestion solutions, and filtration endpoint recognition based on monitoring technology, combined with multi-channel synchronous measurements. Results The fully automatic pretreatment workstation was used to digest and filter 14 standard samples of free silica produced by three institutions, and then detected by pyrophosphate method. The result range of high-, medium-, and low-level free silica standard samples detection was 66.5%-84.8%, 40.0%-44.5%, and 2.1%-24.8%, respectively. The mean relative standard deviations were 3.9%, 1.4% and 1.5%. Conclusion The fully automated pretreatment workstation produced results that met relevant requirements. It can effectively replace the manual digestion and filtration steps of the pyrophosphate method to measure free silica levels in workplace dust and enable rapid detection of free silica in dust samples.
2.Research and Deveplopment Landscape and Industry Trends of Blood Product Enterprises in China and Abroad
Yanan XU ; Jiping HUO ; Qiang WU ; Ding YU ; Hong LIANG ; Rui FU ; Wenli MA ; Wei ZHANG ; Zhigang ZHAO
Herald of Medicine 2025;44(8):1272-1280
The blood products industry,both domestically and internationally,exhibits distinct features in product research,development,and technological innovation.International companies possess extensive expertise in developing immunoglobulins,coagulation factors,and recombinant plasma protein products,demonstrating continuous advancements-particularly in specific immunoglobulin development,long-acting formulation optimization,and manufacturing process improvements.In recent years,Chinese enterprises have also achieved notable progress in related fields,especially in immunoglobulin process refinement and the development of novel recombinant coagulation factor products.However,there remains significant scope for improvement in areas such as the application of recombinant protein technologies,efficient utilization of plasma resources,and the adoption of advanced manufacturing techniques.Additional challenges include the accumulation of patented technologies,the supply of critical raw materials,and access to comprehensive epidemiological data.Driven by ongoing advances in gene recombination technologies,innovations in drug delivery systems,digital transformation,and the rise of personalized medicine,the blood products industry is poised for broader development prospects.To foster sustained and stable domestic industry growth and enhance global competitiveness,Chinese blood product enterprises should intensify their technological accumulation,upgrade manufacturing processes,and optimize plasma resource utilization.
3.Research and Deveplopment Landscape and Industry Trends of Blood Product Enterprises in China and Abroad
Yanan XU ; Jiping HUO ; Qiang WU ; Ding YU ; Hong LIANG ; Rui FU ; Wenli MA ; Wei ZHANG ; Zhigang ZHAO
Herald of Medicine 2025;44(8):1272-1280
The blood products industry,both domestically and internationally,exhibits distinct features in product research,development,and technological innovation.International companies possess extensive expertise in developing immunoglobulins,coagulation factors,and recombinant plasma protein products,demonstrating continuous advancements-particularly in specific immunoglobulin development,long-acting formulation optimization,and manufacturing process improvements.In recent years,Chinese enterprises have also achieved notable progress in related fields,especially in immunoglobulin process refinement and the development of novel recombinant coagulation factor products.However,there remains significant scope for improvement in areas such as the application of recombinant protein technologies,efficient utilization of plasma resources,and the adoption of advanced manufacturing techniques.Additional challenges include the accumulation of patented technologies,the supply of critical raw materials,and access to comprehensive epidemiological data.Driven by ongoing advances in gene recombination technologies,innovations in drug delivery systems,digital transformation,and the rise of personalized medicine,the blood products industry is poised for broader development prospects.To foster sustained and stable domestic industry growth and enhance global competitiveness,Chinese blood product enterprises should intensify their technological accumulation,upgrade manufacturing processes,and optimize plasma resource utilization.
4.TCM Guidelines for Diagnosis and Treatment of Chronic Cough in Children
Xi MING ; Liqun WU ; Ziwei WANG ; Bo WANG ; Jialin ZHENG ; Jingwei HUO ; Mei HAN ; Xiaochun FENG ; Baoqing ZHANG ; Xia ZHAO ; Mengqing WANG ; Zheng XUE ; Ke CHANG ; Youpeng WANG ; Yanhong QIN ; Bin YUAN ; Hua CHEN ; Lining WANG ; Xianqing REN ; Hua XU ; Liping SUN ; Zhenqi WU ; Yun ZHAO ; Xinmin LI ; Min LI ; Jian CHEN ; Junhong WANG ; Yonghong JIANG ; Yongbin YAN ; Hengmiao GAO ; Hongmin FU ; Yongkun HUANG ; Jinghui YANG ; Zhu CHEN ; Lei XIONG
Journal of Nanjing University of Traditional Chinese Medicine 2024;40(7):722-732
Following the principles of evidence-based medicine,in accordance with the structure and drafting rules of standardized documents,based on literature research,according to the characteristics of chronic cough in children and issues that need to form a consensus,the TCM Guidelines for Diagnosis and Treatment of Chronic Cough in Children was formulated based on the Delphi method,expert discussion meetings,and public solicitation of opinions.The guideline includes scope of application,terms and definitions,eti-ology and diagnosis,auxiliary examination,treatment,prevention and care.The aim is to clarify the optimal treatment plan of Chinese medicine in the diagnosis and treatment of this disease,and to provide guidance for improving the clinical diagnosis and treatment of chronic cough in children with Chinese medicine.
5.Analysis of TCOF1 mutation in a Chinese patient with Treacher-Collins syndrome.
Hui HUANG ; Yu YANG ; Xian WU ; Junkai DUAN ; Hong LI ; Lijun YI ; Jingjing FU ; Zhibin GUO ; Ping YUE ; Wenting LI ; Xiaozhen ZHANG ; Xiaochun HUO ; Ka CHEN
Chinese Journal of Medical Genetics 2018;35(5):683-685
OBJECTIVETo detect potential mutation of TCOF1 gene in a Chinese family affected with Treacher-Collins syndrome.
METHODSClinical data of the patient was collected. The analysis included history taking, clinical examination and genetic testing. All coding regions of the TCOF1 gene were subjected to PCR amplification and Sanger sequencing.
RESULTSA novel mutation c.2261ins G (p.E95X) of the TCOF1 gene was discovered in the patient. The same mutation was not found in his parents and 100 healthy controls.
CONCLUSIONThe c.2261insG (p.E95X) mutation of the TCOF1 gene probably underlies the disease in the patient. Genetic testing can facilitate diagnosis and genetic counseling for families affected with TCS.
6.Safety and efficacy of chimeric antigen receptor T cell in the treatment of elderly patients with hematological malignancies.
Dan LIU ; Peng KE ; Li HUO ; Xiao Hui HU ; Cheng Cheng FU ; Cai Xia LI ; Hai Wen HUANG ; Sheng Li XUE ; Hui Ying QIU ; De Pei WU ; Xiao MA
Chinese Journal of Hematology 2018;39(11):952-955
8.Maggot therapy for repairing serious infective wound in a severely burned patient.
Jun-Cheng WU ; Ren-Rong LU ; Ran HUO ; Hong-Bin FU
Chinese Journal of Traumatology 2012;15(2):124-125
The larvae of musca domestica were put in use to discard the dead tissue of a case of severe burn. A total of 50 000 aseptic maggots were put onto the infective wound surface, and aseptic dressings overlaid the surface. Three days later, another 20 000 maggots were put onto the wound for the second therapy. After twice maggot debridement, most necrotic muscle tissues of the wound were cleaned up, and eventually fresh granulation tissue grew and later the wound was covered and healed by 3 times of skin grafting. The result demonstrates that maggot therapy is safe and effective with no adverse complications except pain.
Animals
;
Burns
;
Debridement
;
Humans
;
Larva
;
Skin Transplantation
;
Wound Healing
9.Epidemiologic analysis on severe fever with thrombocytopenia syndrome in Hubei province, 2010
Li LIU ; Xu-Hua GUAN ; Xue-Sen XING ; Xing-Fu SHEN ; Jun-Qiang XU ; Jin-Liang YUE ; Xi-Xiang HUO ; Sha SHA ; Hai-Xiang WU ; Jing HUANG ; Wei JIANG ; Fan DING ; Hang ZHOU ; Wen-Wu YIN ; Qun LI ; Mi-Fang LIANG ; Fa-Xian ZHAN
Chinese Journal of Epidemiology 2012;33(2):168-172
Objective To identify the epidemic characteristics and risk factors of an emerging infectious disease-severe fever with thrombocytopenia syndrome (SFTS) in Hubei province.Methods Active surveillance program on SFTS was set up in monitoring sites-hospitals,at the township level or above,in Suizhou,Huanggang and Wuhan from January to December,2010.Specific surveillance program on SFTS was launched across the province in hospitals above the county level.Cases that matched the definition of surveillance case were identified and reported to Centers for Disease Control and Prevention (CDCs).Cases were interviewed and their blood samples collected and detected using PCR and virus isolation.We also conducted serum antibody surveys among healthy population and livestock and surveillance on vector ticks in those high-epidemic areas.Results 188 cases that matched the definition of surveillance case and 21 deaths were reported in 11 cities,32 countries and 100 towns in 2010,with an incidence rate of 0.33/106.The fatality rate was 11.2%.Data showed that the patients were from hilly areas at the altitude elevated between 28-940 meters.The epidemic period was between April and December with the peak from May to September.The youngest case was an 11-year old,while the eldest was 81 with median age as 56-year old.95.3 % of the patients were farmers.All Patients did not have the history of traveling,two weeks before the onset of SFTS.93.6% of the patients engaged in different kind of work which was associated with agriculture.52.8% of the patients had been exposed to ticks.22.0% of the patients had been bitten by ticks.Skin injury was found in 64.2% of the patients.Samples from 129 cases (68.6%) were collected and detected,with 67.4% of them (87 cases) showed positive by Real time-PCR for SFTS virus.An elevation in antibody titer by a factor of four or evidence of sero-conversion was observed in 11 patients; SFTS virus was isolated from 2 patients.The total antibody positive rates were 3.8%,55.0% (6/11 ),36.7% (2/3) and 80.0% (4/5) respectively in healthy population,dogs,sheep and cows.Ticks from grass,cattle and sheep were detected positive by Real time-PCR.Conclusion Most cases of SFTS in Hubei were infected by SFTS virus,and cases of livestock were infected by SFTS virus.Ticks might serve as an important vector.Skin injury,exposure to tick bites seemed to be the risk factors.
10.Distribution characteristics and risk factors of carotid atherosclerosis in middle-aged and elderly Chinese
Wei WANG ; Yang-Feng WU ; Dong ZHAO ; Ying YANG ; Li-Rong LIANG ; Miao WANG ; Wu-Xiang XIE ; Jia-Yi SUN ; Guang-Hua ZHOU ; Ping SHI ; Fu-Xiu REN ; Yong HUO
Chinese Journal of Cardiology 2010;38(6):553-557
Objective To describe the distribution characteristics of carotid atherosclerosis and to analyze its association with cardiovascular risk factors in middle-aged and elderly Chinese. Methods In 2007, the second cross-sectional examination for cardiovascular risk factors and B-mode ultrasound imaging on carotid arteries were performed in a Chinese population consisting of 2681 subjects aged 43-81 years old from two cohorts participants of the People's Republic of China/United States of America collaborative study (USA-PRC study) and the Chinese multi-provincial cohort study (CMCS). The association of cardiovascular risk factors with intima-media thickening (ITM) and plaque of carotid arteries was analyzed. Results ( 1 )The mean intima-media thickening (Mean-IMT) of carotid artery was 0. 68 mm, the maximal intima-media thickening (Max-IMT) was 1.07 mm. (2)The prevalence rate of carotid plaque was 60. 3% in all subjects.As for the different sites of carotid arteries, the plaque prevalence rate at carotid bulb was 61.2% for male and 51.6% for female( x~2 = 23.44 ,P <0. 01 ), and at the internal carotid artery was 24. 7% for male and 12. 2% for female( x~2 =69.57 ,P <0. 01 ) ,at the common carotid artery was 20. 9% for male and 13.8% for female(x~2 =23.18,P<0. 01 ). (3)After adjusting for age and other cardiovascular risk factors, the MeanIMT and Max-IMT increased with elevated levels of systolic blood pressure, plasma glucose and low density lipoproteins cholesterol (LDL-C)( all P < 0. 05 ). Hypertension, diabetes, smoking and high LDL-C (P <0. 05 ) were independent predict factors for the risk of carotid plaque. Conclusion The carotid atherosclerosis was common in middle and older age Chinese and was positively associated with classical cardiovascular disease risk factors.

Result Analysis
Print
Save
E-mail